AVITHRAPID is a project designed to tackle global challenges in antiviral research through an innovative and multidisciplinary approach. Our vision extends beyond laboratory work and scientific publications—we believe in fostering connections, engaging with the scientific community, and sharing our work with a wider audience.
For this reason, we are pleased to announce our official presence on Bluesky, a platform that is rapidly becoming an important meeting point for scientists, innovators, and professionals across various disciplines.
Why Is AVITHRAPID on Bluesky?
In today’s evolving landscape of scientific communication, it is essential to be where meaningful discussions take place, where new ideas emerge, and where strategic collaborations can be built.
Bluesky is increasingly recognized among researchers for its open structure and ability to support high-quality scientific interactions. A recent Nature survey found that 70% of respondents already use Bluesky to engage in scientific discussions, stay informed about research advancements, and amplify the visibility of their work.
AVITHRAPID aims to be part of this growing ecosystem, bringing its expertise and network into a new space for dialogue and exchange.
A New Step in Our Dynamic Communication Strategy
At AVITHRAPID, we have always adopted an agile and adaptive approach to communication. Our presence across multiple platforms is a reflection of our commitment to engaging with the scientific and innovation community in the most effective way possible.
Joining Bluesky is a strategic extension of this approach, allowing us to:
- Engage with the scientific community by providing a platform for virologists, bioinformaticians, AI specialists, and drug discovery experts to connect and exchange insights.
- Share research updates and findings by communicating AVITHRAPID’s latest advancements in antiviral discovery and clinical development.
- Foster networking and collaborations by creating opportunities for partnerships with research institutions, biotech companies, and key stakeholders in the fight against infectious diseases.
- Promote open science by ensuring that knowledge is shared transparently and accessibly, supporting a more inclusive and collaborative research model.
The Role of Social Media in Scientific Communication
Recent studies highlight how scientific communication is undergoing a major transformation, with researchers increasingly turning to digital platforms to exchange ideas, build collaborations, and enhance the impact of their discoveries.
While specialized academic platforms remain essential for formal scientific discourse, generalist social platforms provide valuable opportunities to increase engagement, connect across disciplines, and reach a broader audience. Digital platforms like Bluesky can facilitate greater accessibility and interdisciplinary dialogue, making scientific discussions more open and dynamic.
Join AVITHRAPID on Bluesky
As we continue to advance research in antiviral drug discovery, we are committed to expanding the conversation and engaging with a global network of scientists, industry leaders, and policymakers. We invite all those interested in antiviral research and innovation to connect with us.
Follow AVITHRAPID on Bluesky: https://bsky.app/profile/avithrapid.bsky.social
Use the hashtag #AVITHRAPID to join the discussion.
Scientific progress thrives on collaboration and knowledge exchange. Our presence on Bluesky represents an opportunity to strengthen these connections and contribute to an open and engaged research community.